Preservation of Spontaneous Breathing in Patients Undergoing Thoracoscopic Surgery

Sponsor
Zhenjiang First People's Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05595096
Collaborator
(none)
59
1
2
12
4.9

Study Details

Study Description

Brief Summary

the aim of this study is to evaluate the advantages of the non-intubation compared with intubation anesthesia on enhanced recovery after thoracoscopic surgery

Condition or Disease Intervention/Treatment Phase
  • Procedure: General anesthesia with preservation of spontaneous breathing
N/A

Detailed Description

All patients will be screened to determine eligibility for study entry, and the patients who meet the eligibility requirements will be informed about the study and potential risks. After giving written informed consent, The patients were randomly divided into non-intubation group and intubation group

Study Design

Study Type:
Interventional
Actual Enrollment :
59 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
non-intubation group: thoracic paravertebral nerve block was performed before anesthesia induction,after anesthesia induction laryngeal mask airway(LMA) is placed. intubation group:were given routine induction with double-lumen endotracheal intubation.non-intubation group: thoracic paravertebral nerve block was performed before anesthesia induction,after anesthesia induction laryngeal mask airway(LMA) is placed. intubation group:were given routine induction with double-lumen endotracheal intubation.
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Comparison of Thoracic Paravertebral Nerve Block Combined Laryngeal Mask Airway With Preservation of Spontaneous Breathing Versus General Anesthesia Using Double-lumen Endobronchial Intubation in Patients Undergoing Thoracoscopic Surgery:
Actual Study Start Date :
Feb 1, 2021
Actual Primary Completion Date :
Jan 31, 2022
Actual Study Completion Date :
Jan 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: spontaneous breathing anesthesia non-intubation group

In this group all the patients with spontaneous breathing anesthesia

Procedure: General anesthesia with preservation of spontaneous breathing
non-intubation group, thoracic paravertebral nerve block was performed before anesthesia induction,when the BIS value drops to between 40 and 60, laryngeal mask airway(LMA) is placed,and observation of breathing

No Intervention: general anesthesia with double-lumen endotracheal intubation group

In this group all the patients with tradition anesthesia with double-lumen endotracheal intubation

Outcome Measures

Primary Outcome Measures

  1. the hospitalized stay [1 year]

    the hospitalized stay

Secondary Outcome Measures

  1. Visual analogue score (VAS) after operation; [1 year]

    Visual analogue score (VAS) was compared between the two groups

  2. The postoperative complications [1 year]

    postoperative nausea and vomiting(PONV), pulmonary infection, atelectasis, sore throat, hoarseness

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 69 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age 18-69 years old

  • Body mass index (BMI) was 18-24 kg / m2

  • American Society of Anesthesiologists' physical classification class I-II

  • The preoperative pulmonary function was normal

Exclusion Criteria:
  • Severe cardiopulmonary disease

  • Severe nervous system diseases

  • Severe blood system diseases

  • Severe liver and kidney dysfunction

  • Conversion to thoracotomy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Affiliated People's Hospital of Jiangsu University Zhenjiang Jiangsu China 212002

Sponsors and Collaborators

  • Zhenjiang First People's Hospital

Investigators

  • Study Director: sun caixia, doctor, Department of Anesthesiology, Affiliated People's Hospital of Jiangsu University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Zhenjiang First People's Hospital
ClinicalTrials.gov Identifier:
NCT05595096
Other Study ID Numbers:
  • Y2021017
First Posted:
Oct 26, 2022
Last Update Posted:
Oct 26, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Zhenjiang First People's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 26, 2022